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Classical nonhomologous end joining (C-NHEJ) is a major mamma-
lian DNA double-strand break (DSB) repair pathway that is required
for assembly of antigen receptor variable region gene segments by
V(D)J recombination. Recombination activating gene endonuclease
initiates V(D)J recombination by generating DSBs between two V
(D)J coding gene segments and flanking recombination signal
sequences (RS), with the two coding ends and two RS ends joined
by C-NHEJ to form coding joins and signal joins, respectively. Dur-
ing C-NHEJ, recombination activating gene factor generates two
coding ends as covalently sealed hairpins and RS ends as blunt
5′-phosphorylated DSBs. Opening and processing of coding end
hairpins before joining by C-NHEJ requires the DNA-dependent pro-
tein kinase catalytic subunit (DNA-PKcs). However, C-NHEJ of RS
ends, which do not require processing, occurs relatively normally
in the absence of DNA-PKcs. The XRCC4-like factor (XLF) is a C-NHEJ
component that is not required for C-NHEJ of chromosomal signal
joins or coding joins because of functional redundancy with ataxia
telangiectasia mutated kinase, a protein that also has some func-
tional overlap with DNA-PKcs in this process. Here, we show that
XLF has dramatic functional redundancy with DNA-PKcs in the V(D)J
SJ joining process, which is nearly abrogated in their combined
absence. Moreover, we show that XLF functionally overlaps with
DNA-PKcs in normal mouse development, promotion of genomic
stability in mouse fibroblasts, and in IgH class switch recombination
in mature B cells. Our findings suggest that DNA-PKcs has funda-
mental roles in C-NHEJ processes beyond end processing that have
been masked by functional overlaps with XLF.
Cernunnos | nej1 | nhej1 | SCID | T-FISH
Double-strand break (DSB) repair is crucial for maintainingstability of the mammalian genome. There are two major
DNA DSB repair pathways in mammalian cells. Homologous
recombination repairs DSBs with high fidelity and is active in
the S/G2 phases of the cell cycle. Classical nonhomologous end
joining (C-NHEJ) rejoins DSBs, often imprecisely, throughout
the cell cycle (1, 2). During C-NHEJ, the Ku70/Ku80 heterodimer
(Ku) recognizes theDSBand recruits theDNA-dependent protein
kinase catalytic subunit (DNA-PKcs) to form a DNA-dependent
protein kinase holoenzyme (DNA-PK). DNA-PK activates the
Artemis endonuclease, which can contribute to the processing of
DSB ends, if necessary, to allow their ligation (3). Ku70/Ku80 also
recruits theXRCC4/DNA ligase 4 (Lig4) complex that ligatesDSB
ends. Ku70, Ku80, XRCC4, and Lig4 are considered to be “core”
C-NHEJ factors because they are required to repair all types of
DSB ends. However, deficiency for Ku70, Ku80, XRCC4, Lig4,
Artemis, or DNA-PKcs abrogates lymphocyte development and
leads to severe combined immunodeficiency (SCID) inmice due to
their requisite role in coding join (CJ) formation (1).
During theB andT lymphocyte development, exons that encode
Ig (Ig) and T-cell receptor variable regions are assembled from V,
D, and J gene segments. This V(D)J recombination process is
initiated by the RAG1/RAG2 (RAG) endonuclease (4). V, D, and
J coding segments are each flanked by RSs that target RAG. RAG
cleaves between the borders of two appropriately paired coding
segments and their flanking recombination signal sequences (RSs)
to generate two hairpin-sealed coding ends (CEs) and two blunt 5′-
phosphorylated RS ends (SEs). The SEs are ligated back together
without further processing, whereas the coding ends must be
opened and processed before they can be joined. Both CE and SE
are joined by C-NHEJ pathway. In this context, Ku and the
XRCC4/Lig4 complex are required for both CJ and signal joins
(SJ) formation. However, although DNA-PKcs and Artemis are
absolutely required for CJ formation due to their role in opening
and processing these ends, RS join formation can occur in their
absence as these ends do not require further processing (1, 2, 4).
IgH class switch recombination (CSR) is a second type of pro-
grammed genome rearrangement that occurs in activated mature
B cells to allow expression of different classes of antibodies. CSR is
initiated by activation-induced cytidine deaminase, the activity of
which results in DSBs in large switch (S) regions flanking different
sets of IgH constant region exons. These DSBs are joined between
two different S regions by C-NHEJ, or in the absence of C-NHEJ,
at reduced levels by alternative end-joining pathways (1). DNA-
PKcs is required for fully normal CSR (5–9).
DNA-PKcs mutations in mice lead to severe combined immune
deficiency due to inability to form V(D)J CJs (10–12). Both point
mutations in the kinase domain of DNA-PKcs (SCID mice) and
elimination of DNA-PKcs expression by gene-targeted mutation
abrogate CJ formation (13–15). However, in the absence of DNA-
PKcs, SJ formation occurs at near normal levels in embryonic stem
cells and pro-B cells (15, 16), but occurs at reduced levels with
decreased fidelity in various nonlymphoid cells (17–19). During
V(D)J recombination, DSBs activate ataxia telangiectasia mutated
(ATM) kinase (4). ATM belongs to the same family of protein
kinases as DNA-PKcs; and, indeed, these two kinases have com-
mon substrates (i.e., histone H2AX). ATM is required for fully
normal chromosomal CJ formation, but it is dispensable for SJ
formation (20). Combined deficiency for ATM and DNA-PKcs in
mice leads to embryonic lethality (21, 22). Moreover, ATM and
DNA-PKcs have redundant functions in SE joining in pro-B cells
(16, 23). When both proteins are inactivated, or when ATM-de-
ficient and DNA-PKcs-deficient pro-B cells are treated with DNA-
PKcs and ATM specific inhibitors, respectively, SE joining is
greatly impaired (16, 23). ATM and DNA-PKcs also have re-
dundant functions in CSR, as switching to IgG1 and IgG3 was
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reduced in ATM-deficient B cells when treated with DNA-PKcs
inhibitors (8).
The XRCC4-like factor (XLF; also called Cernunnos in humans,
or nej1 in yeast) is a C-NHEJ factor that is recruited by Ku (24) and
has structural relatedness to and interacts with XRCC4 (25). Human
XLF deficiency leads to immunodeficiency and developmental
defects (26, 27). Correspondingly, embryonic stem cells and fibro-
blasts from XLF-deficient mice have ionizing radiation sensitivity,
genomic instability, and impaired extrachromosomal V(D)J re-
combination (28). In addition, CSR is reduced in XLF-deficient
mouse B cells (29). However, chromosomal V(D)J recombination is
largely normal in developing lymphocytes and pro-B-cell lines from
XLF-deficient mice (29, 30) because of XLF functional redundancy
with ATM and downstream substrates, including H2AX and 53BP1
in C-NHEJ (31–33). Thus, XLF/ATM and XLF/53BP1 double-de-
ficientmice are smaller than single-deficient littermates, have a SCID
phenotype associated with severely deficient V(D)J CE and SE
joining, and have a greater reduction in CSR than single-deficient
mice (31–33). XLF/H2AX double-deficient pro-B lines also have
severely impaired chromosomal V(D)J recombination (31). In ad-
dition, unjoined CEs and SEs generated during attempted V(D)J
recombination inXLF/H2AXandXLF/53BP1 double-deficient pro-
B cells are highly resected, consistent with a role for H2AX and
53BP1 in endprotection (34–36). It is notable thatATMdeficiency or
treatment withATM inhibitors rescues the end resection, but not the
V(D)J joining phenotype of XLF/H2AX or XLF/53BP1 double-
deficient pro-B lines (31, 32); this is consistent withATMhaving both
a role in end joining and in activating the CtIP nuclease for end re-
section (34). Potential roles for XLF in end protection have been
speculated but not tested.
Results
Combined Deficiency of DNA-PKcs and XLF Affects Mouse Growth and
Viability. Mice with combined deficiency of DNA-PKcs and XLF
(XLFΔ/ΔDNA-PKcs−/−) were obtained from breeding mice het-
erozygous for DNA-PKcs and homozygous for an XLF null allele
(XLFΔ/ΔDNA-PKcs+/−). XLFΔ/ΔDNA-PKcs−/− embryos occur-
red at approximately expected ratios at E15.5 (Fig. 1A), showing
that the double-deficient genotype does not result in early em-
bryonic lethality. However, XLFΔ/ΔDNA-PKcs−/− mice appeared
to be born at sub-Mendelian ratios and few survived past P7
(Fig. 1A) and none of the ones survived past day P10. Live-born
XLFΔ/ΔDNA-PKcs−/− pups were significantly smaller than their
littermates (Fig. 1B). Mice with combined deficiency of Artemis
and XLF (XLFΔ/ΔArtemis−/−) were obtained from breeding mice
heterozygous for Artemis and homozygous for an XLF null allele
(XLFΔ/ΔArtemis+/−). These mice were born at Mendelian ratios
(Fig. 1A) and had no obvious defects beyond expected V(D)J
recombination or genomic stability phenotypes associated with
one or the other single-deficient genotype (see below). We con-
clude that XLF and DNA-PKcs have redundant functions in
mouse development, reminiscent of those associated with core
C-NHEJ deficiencies, and which, correspondingly, are not related
to the role of DNA-PKcs in activating Artemis.
DNA-PKcs kKinase Activity Is Required for V(D)J SJ Formation in XLF-
Deficient Pro-B Lines. Single deficiency for XLF or DNA-PKcs does
not lead tomajor defects in SE joining during chromosomal V(D)J
recombination in pro–B-cell lines (16, 31, 32) (Fig. 2 A–C). How-
ever, double deficiency for XLF and ATM markedly impaired SE
joining (31). As DNA-PKcs and ATM belong to the same family
of protein kinases, we tested whether XLF has functional re-
dundancy with DNA-PKcs. For this, we generated WT, XLFΔ/Δ,
DNA-PKcs−/−, or XLFΔ/ΔDNA-PKcs−/− v-Abl kinase transformed
(v-Abl) pro-B cells harboring a bcl-2 transgene. We treated the
cells with the v-Abl kinase inhibitor STI571 to arrest the cells in
the G1 cell-cycle phase leading to induction of RAG expression and
V(D)J recombination. In these experiments, the bcl-2 transgene
allows cells to survive following STI571 treatment (20). Then, we
assayed SE joining within a chromosomally integrated V(D)J re-
combination substrate (pMX-DEL-SJ) via a Southern blotting with
which we can observe bands corresponding to the unrearranged
cassette (UR), SEs, and SJs. (ref. 20; Fig. 2A).
Pro–B-cell lines from three different XLFΔ/ΔDNA-PKcs−/−
mice were tested, and all showed the same dramatic phenotype,
compared with WT or single mutant lines, which was an accumu-
lation of unjoined SEs consistent with nearly complete abrogation
of SE joining (Fig. 2B). To test if this functional redundancy of
DNA-PKcs involved its kinase activity, we treated both WT and
XLFΔ/Δ v-Abl pro-B cells with DNA-PKcs–specific inhibitor Nu-
7441. Upon STI571 treatment and RAG induction, the XLFΔ/Δ cells
failed to join SEs, whereas vehicle-treated XLFΔ/Δ cells completed V
(D)J recombination as efficiently as WT lines (Fig. 2C). Thus, DNA-
PKcskinase activity is required for efficientSE joining inXLFΔ/Δ cells.
It is notable that the pro-B lines that were double deficient for XLF
and Artemis (XLFΔ/ΔArtemis−/−) efficiently joined the SEs with very
low levels of unjoined SEs consistent with the low levels observed in
XLF-deficient cells alone (Fig. 2D; refs. 31, 32). Thus, the redundant
functions of DNA-PKcs with XLF in SE joining rely on functions of
the DNA-PKcs kinase separate from activation of Artemis.
DNA-PKcs and XLF Have Redundant Functions During CSR. We found
that XLF and DNA-PKcs have redundant functions in SE joining
during V(D)J recombination. To test whether inhibition of DNA-
PKcs activity further impacts CSR in XLF-deficient cells, we ac-
tivated WT or XLFΔ/Δ primary B cells for IgH CSR to IgG1 by
culturing them in the presence of anti-CD40 plus IL-4, in the
presence or absence of two different DNA-PKcs inhibitors (Nu-
7026 and Nu-7441). In this context, treatment of WT-activated B
cells had no significant effect on CSR to IgG1 in WT cells (Fig. 2E
and Fig. S1), as previously observed (8). XLF-deficient B cells
undergo CSR to IgG1 at about 30% the level ofWT B cells at day 3,
Fig. 1. Combined deficiency of DNA-PKcs and XLF significantly affects
mouse growth and survival. (A) The number of live-born mice genotyped at
day 1 (P1) or day 7 (P7), and number of mouse embryos at day E15.5, from
crosses between XLFΔ/ΔDNA-PKcs+/− mice are indicated (Upper). (Lower) The
number of live-born mice (P7) from crosses between XLFΔ/ΔArtemis+/− mice
are indicated. (B) The body weight in grams of the indicated 10-d-old mice
(P10) is plotted. The numbers represent the average and SD from at least 3
mice of each genotype. *P = 0.01 and ***P = 0.0003.






and 40% the level of WT B cells at day 4. Treatment with
DNA-PKcs inhibitors reduced levels to about 20% of WT at day
3, and 25% of WT at day 4, the latter of which is about the level
of CSR observed via alternative end joining in the complete ab-
sence of C-NHEJ (Fig. 2E; refs. 31, 37). Therefore, XLF and
DNA-PKcs appear to have redundant functions in CSR.
Unjoined RS Ends Are Not Excessively Resected in Absence of XLF. SEs
and CEs are excessively resected in cells double deficient for XLF
and histone H2AX, and to a lesser extent in cells deficient for
XLF andATMor XLF and 53BP1 (31, 32). Although XLF appar-
ently does not prevent increased end resection in the combined
absence of ATM or H2AX and either Artemis or Lig4 (34), ability
of XLF to contribute to end protection through a different
mechanism has not been tested. In this regard, we did not observe
any evidence of increased resection of the unjoined SEs that
accumulate in the absence of XLF and DNA-PKcs (Fig. 2 B and
C; resection would be indicated by a “smear” or heterogeneous
bands below the SE band as observed in refs. 31, 32, 34; see be-
low). In a similar fashion, when we used the pMX-DEL-CJ V(D)
J substrate to detect CEs and CJs in XLFΔ/ΔDNA-PKcs−/− v-Abl
pro–B-cell lines versus the various controls, we found no evidence
of increased resection of unjoined CEs (Fig. 3 A and B; note the
heterogeneous smear of bands below the CE band in XLFΔ/Δ
cells treated with ATM inhibitor as positive control). In theory,
lack of resection of unjoined CEs or SEs in the XLF/DNA-PKcs
Fig. 2. XLF and DNA-PKcs have redundant functions for signal end joining and CSR. (A) Schematic diagram of chromosomally integrated V(D)J signal join
cassette, pMX-DEL-SJ. (B–D) Southern blotting with C4 probe of DNA digested with EcoRV. The DNA was isolated from v-Abl pro–B-cell lines, with chromosomally
integrated pMX-DEL-SJ cassettes, treated with STI571 for 2 or 4 d, and with DNA-PKcs inhibitor Nu-7441, when indicated. Detected bands are UR substrates, SJ,
and SE. (E) IgG1 CSR levels of α-CD40/IL4-stimulated primary B cells (day 3 and day 4; n = 5 mice per genotype analyzed in independent experiments). Cell viability
was not different between WT and XLFΔ/Δ stimulated B cells based on flow cytometric forward- and side-scatter profiles; DNA-PKcs inhibitor (Nu-7026) treatment
also did not significantly affect cell viability, irrespective of genotype. Cell proliferation at day 3 (calculated as fold increase in starting cell number) (37), when
proliferation is still robust, was not significantly affected by DNA-PKcs inhibitor: WT vs. WT + Nu-7026, 5.7+/− 0.73 vs. 4.9+/− 0.92, P = 0.20; XLFΔ/Δ vs. XLFΔ/Δ + Nu-
7026, 5.9+/−1.43 vs. 4.7 +/− 1.57, P = 0.25; nor was it affected on day 4: WT vs. WT +Nu-7026, 7.8 +/− 3.41 vs. 8.1 +/− 2.99, P = 0.86; XLFΔ/Δ vs. XLFΔ/Δ +Nu-7026, 7.6 +/−
3.26 vs. 7.2 +/− 1.97, P = 0.79. Day 3 switching: **P = 0.0052; n.s., not significant (P = 0.39). Day 4 switching: **P = 0.01; n.s., not significant (P = 0.74), based on
unpaired two-tailed t test. An independent set of CSR experiments using DNA-PKcs inhibitor Nu-7441 gave the same general results and is shown in Fig. S1.
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double mutants might reflect some unknown role of DNA-PKcs,
similar to that found for ATM (34), in activating resection.
However, we also found no increased resection of unjoined CEs
that accumulate in hairpin form in XLFΔ/ΔArtemis−/− and as
opened ends in XLFΔ/ΔXRCC4−/− v-Abl transformed pro-B lines
(Fig. 3 C and D). We conclude that, based on the resolution of
currently available assays, XLF is not required for protection of
free coding ends during V(D)J recombination.
XLF Has Redundant Functions with DNA-PKcs in Maintaining Genomic
Stability. Combined deficiency for XLF and DNA-PKcs leads to
a nearly complete block of SE joining in the V(D)J recombination
Fig. 3. Free CEs do not show increased resection in
the absence of XLF. (A) Schematic diagram of chro-
mosomally integrated V(D)J coding join cassette,
pMX-DEL-CJ. (B–D) Southern blotting with C4 probe
of DNA digested with EcoRV. The DNA was isolated
from the indicated v-Abl pro–B-cell lines, with chro-
mosomally integrated pMX-DEL-CJ cassettes, treated
with STI571 for 2 or 4 d, and with ATM inhibitor Ku-
55933, when indicated. Increased CE resection is in-
dicated by the bracket labeled “resected CE” in the
XLFΔ/ΔATMinhibitor lane.






assay and to substantial inhibition of CSR to IgG1. To quantify
potential effects on genome stability, we applied telomere
fluorescence in situ hybridization (T-FISH) to quantify chro-
mosome and chromatid breaks in tail fibroblasts from the various
mouse lines. Levels of abnormal metaphases in XLFΔ/ΔDNA-
PKcs−/− fibroblasts (25.5%), were similar to those found in
Ku70−/− cells (27.6%, P = 0.69), and significantly higher than in
XLFΔ/Δ cells (12.0%, P = 0.02) or DNA-PKcs−/− cells (12.4%,
P= 0.01), or wild type cells (3.6%, P= 0.0004) (Fig. 4A). Levels
of chromosomal abnormalities in XLFΔ/ΔArtemis−/− cells
(12.0%) were similar to that of XLFΔ/Δ cells (P = 1,0), consistent
with our finding that Artemis deficiency did not lead to increased
defects in joining of V(D)J SEs in the absence of XLF (Fig.
2D). In XLFΔ/ΔDNA-PKcs−/− fibroblasts, levels of chromosome
breaks were much higher than those of chromatid breaks,
indicating that, as observed for C-NHEJ–deficient lines pre-
viously (32, 38), most unrepaired DSB accumulated in pre-
replicative phases of the cell cycle. We conclude that the XLF and
DNA-PKcs also have redundant functions in promoting genomic
stability.
Discussion
We find that XLF and DNA-PKcs functionally overlap in a variety
of processes that rely on core C-NHEJ factors. Thus, RS joining
duringV(D)J recombination, which is known to be fully dependent
on core C-NHEJ factors (1–4), occurs relatively normally in the
absence of DNA-PKcs or XLF but is nearly abrogated in their
combined absence (Fig. 2 B and C). Likewise, IgH CSR to IgG1
occurs normally in the absence of DNA-PKcs (5–7) or whenDNA-
PKcs kinase is inhibited (8), and at somewhat reduced efficiency in
the absence of XLF (29); but CSR to IgG1 is further reduced to
levels observed in the absence of core C-NHEJ factors in XLF-
deficient cells treated with DNA-PKcs kinase inhibitors (Fig. 2E
and Fig. S1). Spontaneous genomic instability, as assessed by
analysis of metaphase karyotypes is only moderately affected by
DNA-PKcs orXLFdeficiency alone (9, 28, 32), but their combined
deficiency increases levels to those found in cells deficient for
a core C-NHEJ factor (Ku70) with primarily chromosome breaks
as observed in cells with core C-NHEJ deficiencies (Fig. 4). Finally,
DNA-PKcs or XLF deficiency do not greatly impact mouse de-
velopment outside of the lymphoid systembut combined deficiency
leads to major growth defects and late prenatal or early postnatal
lethality, reminiscent of some core C-NHEJ defects (Fig. 1). To-
gether, these findings strongly indicate that XLF and DNA-PKcs
provide redundant functions that are required for some aspects of
the core C-NHEJ reaction.
Precisely how XLF and DNA-PKcs functionally overlap in C-
NHEJ remains to be determined. Given that DNA-PKcs inhibitor
treatment reveals the same functional XLF overlaps asDNA-PKcs
deficiency where tested, one possibility is overlapping functions
between XLF and DNA-PKcs substrates (Fig. 2 B and C). In this
regard, Artemis and XLF do not have detectable overlapping
functions in any tested process, which argues against the XLF
overlapping function with DNA-PKcs involving currently known
DNA-PKcs roles in end processing (Figs. 2D and 4A). Our findings
also indicate that XLF is not required for end protection in DNA-
PKcs or other C-NHEJ-factor–deficient cells, where ATM sub-
stratesH2AXand 53BP1 are present and known to function in that
capacity (Figs. 2 B and C and 3). DNA-PKcs long has been sug-
gested to have direct roles in end synapsis and potential roles for
DNA-PKcs substrates are conceivable. ATMand its substrates also
have been suggested to function in DSB synapsis (20, 39). It is
notable that combined deficiency for ATM and DNA-PKcs leads
to decreasedRS joining (16, 23), but not nearly to the extent found
in the absence of either ATM or DNA-PKcs and XLF (ref. 31 and
Fig. 2 B and C). Thus, XLF has functional redundancy with both
proteins that cannot be compensated by either DNA-PKcs or
ATM alone. Such a function may be through directly overlapping
roles in the same process or through roles in very different pro-
cesses that functionally overlap (31). For example, all three pro-
teins might contribute directly to synapsis, or, alternatively, DNA-
PKcs and ATM might contribute to synapsis, and XLF could
recruit repair factors to enhance the kinetics with which C-NHEJ
ligates ends before they separate. Many other possible direct or
Fig. 4. Genomic instability in mice tail fibroblasts.
(A) Telomere FISH analysis of metaphases from WT,
XLFΔ/Δ, DNA-PKcs−/−, XLFΔ/ΔDNA-PKcs−/−, Artemis−/−,
XLFΔ/ΔArtemis−/−, and Ku70−/− fibroblasts. 200–250
total metaphases from four or five different mice,
respectively, of each indicated genotype were ana-
lyzed. Numbers of different types of metaphase
anomalies are indicated. (B) Examples of intact and
abnormal chromosomes, including chromosome
and chromatid breaks. Telomeres are in red (Cy3),
and DNA is in blue (DAPI).
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indirect functionally redundant roles could be imagined in the
context of proposed overlapping activities of ATMandDNA-PKcs
(8, 16, 23). Whatever their redundant functions with XLF, DNA-
PKcs and ATM have distinct roles, as neither can substitute for
XLF in the absence of the other.
Materials and Methods
Mice. All experiments involving mice were performed according to protocols
approved by the Animal Resources Care Facility of Boston Children’s Hospital
(ARCH). Artemis+/− (40), DNA-PKcs+/− (15), Eμ-Bcl2+ (41), Ku70+/− (42), XLF+/Δ
(29), and XRCC4c/+ (43) mice were previously described.
Chromosomal V(D)J Recombination Assays. V(D)J recombination with an in-
tegrated substrate was previously described (20, 31, 32). Where indicated,
the cells were treated with 15 μM of ATM inhibitor Ku-55933 (Tocris Bio-
science) or 5 μM of Nu-7441 DNA-PKcs inhibitor (Tocris Bioscience). XLFΔ/
ΔXRCC4C/C v-Abl clones with independent V(D)J cassette single integrations
were treated with Tat-Cre and screened for Xrcc4−/− subclones as described
(31, 44).
Class Switch Recombination Assay. Assays for IgH class switch recombination
to IgG1 were carried out as previously described (37). In brief, mature B cells
were isolated and pretreated with either DMSO vehicle or 5 μM of Nu-7026,
or 5 μM of Nu-7441 (Tocris) and stimulated with anti-CD40 plus IL-4 . Cells
were assessed for switching to IgG1 by fluorescence activated cell sorting on
day 4 as described.
Primary Murine Tail Fibroblasts. Primary tail fibroblasts were generated as
described (32). In brief, skin frommouse tail was removed and cut with blade to
obtain pieces of about 2 mm × 2 mm. The skin pieces were treated 24 h with 2
mg/mL collagenase II (Gibco) in DMEM supplemented with 10% (vol/vol) heat-
inactivated FCS and antibiotics, at 37 °C, 5% (vol/vol) CO2 incubator. Then, the
skin pieces were homogenized in 10-mL pipette by moving up and down, and
filtered through a 70-μm nylon cell strainer (BD Falcon). Subsequently, the cells
were washed in DMEMwith 10% (vol/vol) FCS, and plated. Fibroblasts from the
second or third passages were used for the telomere FISH assay.
Telomere FISH Assay. Metaphases were prepared and chromosomal aberra-
tions were counted as described (32). The mouse tail fibroblasts were treated
with 100 ng/mL colcemid (KaryoMax, Gibco) for 6 h. Then, the cells were
treated with trypsin in PBS solution, washed with PBS, and lysed in 75 mM
KCl (37 °C, 20 min). Subsequently, fibroblasts were fixed in methanol:acetic
acid (3:1) as described (38). Telomeres were visualized with a Cy3-labeled
(CCCTAA)3 probe (Applied Biosystems), and DNA was visualized with DAPI.
Images were obtained with Eclipse microscope (Nikon). Loss of telomere
signal from both sister chromatids was defined as chromosomal break. Loss
of telomere signal from one of the chromatids or clear absence of DAPI in
the middle of one chromatid was defined as chromatid break.
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